Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer

Pemetrexed is approved as a first-line treatment for advanced non-squamous non-small cell lung cancer (NSCLC) with cisplatin and as a single agent for second-line treatment or for patients who show no disease progression after four cycles of platinum-based doublet induction chemotherapy as maintenan...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyeong-Hyun, Song, Seo-Young, Lim, Kyu-Hyoung, Han, Seon-Sook, Kim, Se-Hyun, Cho, Jun Hwi, Park, Chan Woo, Lee, Seoungkoo, Lee, Hui-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629367/
https://www.ncbi.nlm.nih.gov/pubmed/23613674
http://dx.doi.org/10.4143/crt.2013.45.1.74

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629367/
https://www.ncbi.nlm.nih.gov/pubmed/23613674
http://dx.doi.org/10.4143/crt.2013.45.1.74

Ejemplares similares